Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aurobindo Pharma: Classification Of US FDA Inspection At Unit-III Of Eugia Pharma Specialities Limited Pashamylaram (Our Wholly Owned Subsidiary) As OAI
News Announcement

Aurobindo Pharma: Classification Of US FDA Inspection At Unit-III Of Eugia Pharma Specialities Limited Pashamylaram (Our Wholly Owned Subsidiary) As OAI

12-Jun-2026 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

Intimation of US FDA Inspection at Unit-III of Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company as OAI.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.